
Carmen Muñoz Almagro
Jefe de Grupo Senior
Research group
Professional network profiles
Related websites
Last Publications
- Zhao C, Zhang T, Guo L, Sun S, Miao Y, Yung CF, Tomlinson J, Stolyarov K, Shchomak Z, Poovorawan Y, Nokes DJ, Munoz-Almagro C, Mandelboim M, Keck JW, Langley JM, Heikkinen T, Deng J, Colson P, Chakhunashvili G, Caballero MT, Bont L, Feikin DR, Nair H, Wang X and Li Y Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic. NATURE COMMUNICATIONS . 16(1): 1610-1610.
- Savulescu C, Prats-Uribe A, Brolin K, Uusküla A, Bergin C, Fleming C, Zvirbulis V, Zavadska D, Szuldrzynski K, Gaio V, Popescu CP, Craiu M, Cisneros M, Latorre-Millán M, Lohur L, McGrath J, Ferguson L, Abolina I, Gravele D, Machado A, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sui J, Kenny C, Krievins D, Barzdina EA, Melo A, Kosa AG, Miron VD, Munoz-Almagro C, Milagro AM, Bacci S, Kramarz P and Nardone A Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023) Vaccine . 45: 126615-126615.
- Shaw D, Torreblanca RA, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, Casanova C, Choi EH, Claus H, Corcoran M, Cottrell S, Cunney R, Cuypers L, Dalby T, Davies H, de Gouveia L, Deghmane AE, Desmet S, Domenech M, Drew R, Plessis MD, Duarte C, Fuursted K, Golden A, Almeida SCG, Henares-Bonilla D, Henriques-Normark B, Hilty M, Hoffmann S, Humphreys H, Jacobsson S, Johnson C, Jolley KA, Kawabata A, Kozakova J, Kristinsson KG, Krizova P, Kuch A, Ladhani S, Lâm TT, Ayala MEL, Lindholm L, Litt D, Maiden MCJ, Martin I, Martiny D, Mattheus W, McCarthy ND, Meehan M, Meiring S, Mölling P, Morfeldt E, Morgan J, Mulhall R, Munoz-Almagro C, Murdoch D, Musilek M, Novakova L, Oftadeh S, Pérez-Argüello A, Pérez-Vázquez MD, Perrin M, Prevost B, Roberts M, Rokney A, Ron M, Sanabria OM, Scott KJ, Sempere J, Siira L, de Lemos APS, Sintchenko V, Skoczynska A, Slotved HC, Smith AJ, Taha MK, Toropainen M, Tzanakaki G, Vainio A, van der Linden MPG, van Sorge NM, Varon E, Moreno JV, Vohrnova S, von Gottberg A, Yuste J and Brueggemann AB The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance. LANCET DIGITAL HEALTH . : .
Projects
- Project name:
- Estudio de la capacidad de resilencia a largo y corto plazo de la microbiota nasofaríngea y su implicación en el paso de la colonización a enfermedad invasiva por bacterias patobiontes
- Leader
- Carmen Muñoz Almagro
- Funding entities:
- Muñoz Almagro, Carmen, Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
- Code
- PI23/00049
- Starting - finishing date:
- 2024 - 2026
- Project name:
- Subvenció per a la incorporació de personal de suport als grups de recerca, corresponent als anys 2023-2025
- Leader
- Carmen Muñoz Almagro
- Funding entities:
- Generalitat de Catalunya
- Code
- SLT028/23/000262
- Starting - finishing date:
- 2023 - 2025
- Project name:
- Epidemiología molecular de profagos de neumococo y su potencial impacto en el desarrollo de enfermedad invasiva neumocócica en niños.
- Leader
- Carmen Muñoz Almagro
- Funding entities:
- Societat Catalana de Malalties Infeccioses i Microbiologia
- Code
- PCP00362
- Starting - finishing date:
- 2023 - 2024
News
-
International travel affects gut microbiota
A collaborative study between the Institut de Recerca Sant Joan de Déu (IRSJD) and the Institut d'Investigació i Innovació Parc Taulí (I3PT) demonstrates that traveling and being exposed to new people, traditions, cultures, and unfamiliar foods can change gut microbiota and its diversity.
-
Carmen Muñoz-Almagro has been honored by the Barcelona Medical Association for her career in biomedical research
Dr. Carmen Muñoz-Almagro, a researcher from the Institut de Recerca Sant Joan de Déu, has been honored with one of the Professional Excellence Awards, which are annually bestowed by the Barcelona Medical Association.
-
New insights into COVID-19 protection in children have revealed the presence of sACE2 in the saliva
The presence of the soluble angiotensin-converting enzyme 2 (sACE2) in saliva could have implications for COVID-19 infection, prevention and control, according to researchers from the Institut de Recerca Sant Joan de Déu and the University of Catalunya. This study has been published in Scientific Reports.
More activities
-
Defensa tesi doctoral: Daniel Penela Sánchez
Auditori Plaza, Hospital Sant Joan de Déu · Online